Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RELA | Q04206 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.66 |
| ▸ | GLA | P06280 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.66 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.64 |
| ▸ | NQO2 | P16083 | 2/20 | 0.60 |
| ▸ | PLG | P00747 | 1/20 | 0.59 |
| ▸ | PLAU | P00749 | 1/20 | 0.59 |
| ▸ | PLAT | P00750 | 1/20 | 0.59 |
| ▸ | KLK1 | P06870 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.52 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.52 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.52 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5407848 | 1.00 | RELA (1.00) | RELAALDH1A1GLAMAPTSMN1; SMN2 | |
| SCHEMBL5407847 | 1.00 | RELA (1.00) | RELAALDH1A1GLAMAPTSMN1; SMN2 | |
| SCHEMBL30507765 | 1.00 | RELA (1.00) | RELAALDH1A1GLAMAPTSMN1; SMN2 | |
| SCHEMBL11268864 | 0.95 | RELA (0.91) | RELAALDH1A1GLAMAPTSMN1; SMN2 | |
| SCHEMBL11209385 | 0.95 | RELA (0.91) | RELAALDH1A1GLAMAPTSMN1; SMN2 | |
| SCHEMBL5406013 | 0.93 | RELA (0.87) | RELAALDH1A1GLAMAPTSMN1; SMN2 | |
| SCHEMBL5406016 | 0.93 | RELA (0.87) | RELAALDH1A1GLAMAPTSMN1; SMN2 | |
| SCHEMBL5406009 | 0.93 | RELA (0.87) | RELAALDH1A1GLAMAPTSMN1; SMN2 | |
| SCHEMBL9166699 | 0.93 | RELA (0.86) | RELAALDH1A1GLAMAPTSMN1; SMN2 | |
| SCHEMBL9166695 | 0.93 | RELA (0.86) | RELAALDH1A1GLAMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114591136-B | Synthesis method of 2-phenyl anthracene | 西安瑞联新材料股份有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-114591136-A | Synthetic method of 2-phenylanthracene | 西安瑞联新材料股份有限公司 | 2022-06-07 | — | — | CN | claimed |
| CN-101889959-A | Be used to improve the encapsulated fluorescent whitening compositions of appearance | CIBA SC HOLDING AG | 2010-11-24 | — | — | CN | claimed |
| CN-101001992-A | Fluorescent pigments for coating compositions | CIBA SC HOLDING AG (CH) | 2007-07-18 | — | — | CN | claimed |
| CN-1265645-A | Urokinase inhibitors | ABBOTT LAB (US) | 2000-09-06 | — | — | CN | claimed |
| US-4756989-A | Aluminum or silicon substrate, copolymer resist layer comprising vinyl aromatic, ethylenically unsaturated units | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1988-07-12 | — | — | US | claimed |
| US-4734824-A | MONOOLEFIN OR DIOLEFIN HAVING THREE CONDENSED OR NONCONDENSED AROMATIC RINGS | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1988-03-29 | — | — | US | claimed |
| CN-114591136-B | Synthesis method of 2-phenyl anthracene | 西安瑞联新材料股份有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-114591136-B | Synthesis method of 2-phenyl anthracene | 西安瑞联新材料股份有限公司 | 2024-03-26 | — | — | CN | disclosed |
| US-20230399350-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-12-14 | — | — | US | disclosed |
| CN-116964186-A | Toilet edge block with smell change | 西姆莱斯股份公司 | 2023-10-27 | — | — | CN | disclosed |
| US-20230292592-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-14 | — | — | US | disclosed |
| US-20230292586-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-14 | — | — | US | disclosed |
| US-4621302-A | MONO-OR DIOLEFIN HAVING THREE CONDENSED OR NON-CONDENSED AROMATIC RINGS | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1986-11-04 | — | — | US | disclosed |
| EP-0180771-A1 | Method for improving impulse breakdown strength of electrically insulating materials | Nippon Petrochemicals Co., Ltd. (JP) | 1986-05-14 | — | — | EP | disclosed |
| EP-0154993-A1 | Electrical insulating oil and electrical appliances impregnated with the same | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1985-09-18 | — | — | EP | disclosed |
| US-4335055-A | Process for the preparation of alkenylbenzene derivatives or alkenylnaphthalene derivatives | CIBA-GEIGY CORPORATION (US) | 1982-06-15 | — | — | US | disclosed |
| US-4158099-A | FROM SCHIFF BASES AND BIPHENYL COMPOUND | CIBA-GEIGY AG (CH) | 1979-06-12 | — | — | US | disclosed |
| US-4140641-A | NONIONIC SURFACTANT, IMIDAZOLINIUM QUATERNARY COMPOUND | COLGATE-PALMOLIVE COMPANY (US) | 1979-02-20 | — | — | US | disclosed |
| US-3991049-A | Aromatic compounds containing ethylene double bonds, processes for their manufacture and use | CIBA-GEIGY AG (CH) | 1976-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230399350-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, OSBP | RELA 3480/4885ALDH1A1 504/4885GLA 1583/4885 |
| US-20230292592-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, OSBP | RELA 3480/4885ALDH1A1 504/4885GLA 1583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.